Vonetize. After delay, launch of operations in Russia expected by the end of 2018; the company needs additional sources of funding; acquisition by Desilu Studios is still awaiting completion; target price has been reduced to NIS 1.00.

• jaimeuss_admin
• 2 בOctober 2018
• Research
• 0 Comments

Continue Reading

Kadimastem has raised NIS 15M which will fund clinical and pre-clinical development for cellular therapy; target price unchanged.

• jaimeuss_admin
• 2 בOctober 2018
• Research
• 0 Comments

Continue Reading

SAFE-T. NASDAQ IPO – $7.3M raised strengthens equity structure; significant growth in revenues and backlog offset by a substantially increased burn rate due to operational and technological expansion; valuation retained, however due to additional shares, target price decreased to NIS 3.85.

• jaimeuss_admin
• 2 בOctober 2018
• Research
• 0 Comments

Continue Reading